[
  {
    "info": {
      "NCT": "NCT03785249",
      "Protocol_No": "849-001",
      "jit": "Tempus, Caris",
      "trial_name": "Mirati Therapeutics KRYSTAL-1"
    },
    "disease": {
      "summary": "Advanced, metastatic solid tumors with KRAS G12C mutation",
      "details": [
        {
          "code": "Colorectal Cancer",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Lung Cancer, NOS",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Non-Small Cell Lung Cancer (NSCLC)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Pancreatic Adenocarcinoma (PAAD)",
          "selection": "include",
          "stage": "Advanced Stage"
        },
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Advanced Stage"
        }
      ]
    },
    "query": {
      "nct": "NCT03785249",
      "title": "Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
      "current_status": "Recruiting",
      "status_verif_date": "February 2022",
      "last_update_date": "February 4, 2022",
      "trial_hold_status": "open",
      "sponsor": "Mirati Therapeutics Inc.",
      "brief_summary": "This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a KRAS G12C mutation.",
      "conditions": "Advanced Cancer | Metastatic Cancer | Malignant Neoplastic Disease",
      "type": "Interventional",
      "phase": "Phase 1 | Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Phase 1 Dose Exploration",
          "drug": "MRTX849 | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Phase 1 Dose Exploration",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Phase 1b Expansion",
          "drug": "MRTX849 | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Phase 1b Expansion",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "3",
          "cohortlabel": "Phase 2",
          "drug": "MRTX849 | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Phase 2",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            },
            {
              "cohort": "Phase 2",
              "Gene": "STK11",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "SKT11 Mutation  "
            }
          ]
        },
        {
          "ArmID": "4",
          "cohortlabel": "Pilot Phase 1b Combination with Pembrolizumab",
          "drug": "MRTX849 | Pembrolizumab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Pilot Phase 1b Combination with Pembrolizumab",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "5",
          "cohortlabel": "Pilot Phase 1b Combination with Cetuximab",
          "drug": "MRTX849 | Cetuximab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "closed",
          "biomarker": [
            {
              "cohort": "Pilot Phase 1b Combination with Cetuximab",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "6",
          "cohortlabel": "Pilot Phase 1b Combination with Afatinib",
          "drug": "MRTX849 | Afatinib",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Pilot Phase 1b Combination with Afatinib",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "7",
          "cohortlabel": "Phase 2 Combination with Cetuximab",
          "drug": "MRTX849 | Cetuximab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Phase 2 Combination with Cetuximab",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "8",
          "cohortlabel": "Pilot Phase 1b Combination with Cetuximab in NSCLC",
          "drug": "MRTX849 | Cetuximab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Pilot Phase 1b Combination with Cetuximab in NSCLC",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "9",
          "cohortlabel": "Pilot Phase 1b Combination with Cetuximab in PDAC",
          "drug": "MRTX849 | Cetuximab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Pilot Phase 1b Combination with Cetuximab in PDAC",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-30",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT03785249\" target=\"_blank\">NCT03785249<\/a>"
    }
  }
]
